Ruben Garcia's appointment as General Counsel is a key milestone for FibroBiologics. His expertise in public company reporting, corporate governance, healthcare compliance, and strategic transactions is set to boost the company's leadership and efficiency, and aid its clinical and pre-clinical pipelines.
FibroBiologics股票討論區
$BiomX(PHGE.US)$ $Larimar Therapeutics(LRMR.US)$ $Clene(CLNN.US)$ $Glucotrack(GCTK.US)$ $Sonnet BioTherapeutic(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
暫無評論